Health news

Actoverco Pharmaceutical Company

عناوین برگزیده

Selected titles

Actover Pharmaceutical Group Participates in the 10th IRAN PHARMA Exhibition

Actover Pharmaceutical Group, with active participation in the 10th edition of the Pharmaceutical and Related Industries Exhibition (IRAN PHARMA), hosted chief executives of several pharmaceutical

Actoverco Medical Director Stated: A Strong Commitment to the “Pharmacovigilance” System Ensures the Safety and Reliability of Actover Products

The first National Conference on “Health Product Vigilance” was held on the occasion of World Patient Safety Day by the Deputy for Food and Drug

Actover Group Unveils “Zeponim” for the Management of Multiple Sclerosis and Ulcerative Colitis

Here’s the English translation of that sentence: **The oral capsule *Zeponim* (Ozanimod), developed by specialists at Alborz Zagros Pharmaceutical Company — a subsidiary of Actover

Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025

Tehran, July 2025 – At the sidelines of the 13th Iran Supplex,Iran’s leading exhibition and congress for dietary, nutritional, and sports supplements.

Latest news

nahaleh naraqi owner of actoverco

Bright future for pharmaceutical industry in Iran!

Nahaleh Naraqi said that Although Iran's economy is going through difficult years, this industry has managed to pass the year 2023 with better conditions in

Helping to Treat Neuropathic Pain and Anemia with an Iranian Supplement

In a ceremony attended by specialists in endocrinology, neurology, and nutrition, Nexus, a subsidiary of the Actoverco Pharmaceutical Group, unveiled its new product, "Neurostyle."

Explanation of the manufacturer of the news-making drug “Losartan”

Following the Food and Drug Administration's order to collect Losartan drug with Indian active ingredient from the supply level, the Iranian company "Actoverco" announced in

Application of CPB technology in production of Actoverco’s Interferon beta 1-a

According to Actoverco’s Public Relations, we are currently producing the raw material of interferon beta-1a from the cell line in the Actover Group in the

Appreciation of the sacrificers (Isargar) working in Actoverco Company

On the occasion of Arba’een, 150 sacrificers (Isargar) working in the Actover group were appreciated and honored

Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology

Tehran, May 2025 — Actover Pharmaceutical Group participated in the 32nd Iranian Congress of Neurology and Clinical Electrophysiology, presenting a wide range of its neurological

Actoverco’s attendance at the 3rd international Razavi cardiovascular congress (Caspian and CTO)

The 3rd international Razavi cardiovascular congress was held in Razavi Hospital from 9 to 11 October 2019 for 3 days

Actero Middle East’s attendance in the 18th Congress of the Iranian Society of Medical Oncology and Hematology

The 18th National Congress of the Oncology and Hematology Society and the Cancer Nursing Conference were held from November 14th to 16th, 2019 at the

The effect of stress on digestive system

The gastrointestinal system and central nervous system are connected by different nerve fibers or neurons

Hygiene during wearing mask

Nowadays, one of the ways to reduce the spread of coronavirus and protection from it, is to use a mask

Thyroid hormone regulating drugs

The thyroid gland is responsible for secreting the thyroxine (T4) and triiodothyronine (T3) hormones.